YD Bio YDES
NASDAQ YDES
$2.63 +0.00 (+0.19%)
As of: Sep 22, 2026 · 11:58 AM EDT

YD Bio (YDES) Operating Leases (2024)

YD Bio's (YDES) quarterly Operating Leases came in at $5684.0 in Q4 2024.

Analysis

YD Bio (YDES) Operating Leases (2024) Analysis & Trends

YD Bio (YDES) has reported Operating Leases for 1 consecutive years, with $5684.0 the latest figure, recorded in Q4 2024.

  • On a quarterly basis, Operating Leases changed N/A year-over-year to $5684.0 in Q4 2024; TTM through Dec 2024 was $5684.0, a N/A change from a year earlier, with the FY2024 full-year figure at $5684.0, changed N/A from the prior year.
  • Operating Leases was $5684.0 for Q4 2024 at YD Bio.
  • Over five years, Operating Leases peaked at $5684.0 in Q4 2024 and troughed at $5684.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 YD Bio 225.82 Mn 223.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 5,684.00
API Access

YD Bio Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=YDES&period=max&api_key=YOUR_API_KEY